Abstract 3755: Comprehensive antitumor immune activation by a novel TLR7/8 targeting agent NKTR-262 combined with CD122-biased immunostimulatory cytokine NKTR-214Saul Kivimäe, Jonathan Zalevsky, Wildaliz Nieves et al.|Cancer Research|2018Cited by 19
1086 NKTR-288, a polymer-conjugated interferon gamma mutein for the treatment of solid tumorsDamon J. Hamel, Jonathan Zalevsky, Marlene Hennessy et al.|Regular and Young Investigator Award Abstracts|2022Cited by 0